COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,649 Articles (22,913 medRxiv, 8,736 bioRxiv)

Most recent first Previous |  Page 1050: Articles 10491-10500  | Next

Adolescents Hospitalized with SARS-CoV-2: Analysis of Clinical Profile and Risk Factors for Severe Disease over a two-year period
Ghosh, T., Suri, T. M., Jat, K. R., Gupta, A. K., Bhatnagar, S., Tiwari, P., Mittal, S., Mohan, A.
10.1101/2022.01.06.22268674 — Posted: 2022-01-07
A 2-Gene Host Signature for Improved Accuracy of COVID-19 Diagnosis Agnostic to Viral Variants
Albright, J., Mick, E., Sanchez-Guerrero, E., Kamm, J., Mitchell, A., Detweiler, A. M., Neff, N., Tsitsiklis, A., Hayakawa Serpa, P., Ratnasiri, K., Havlir, D., Kistler, A., DeRisi, J., Pisco, A. O., Langelier, C.
10.1101/2022.01.06.21268498 — Posted: 2022-01-07
Effect of Vaccination on Household Transmission of SARS-CoV-2 Delta VOC
Lyngse, F. P., Molbak, K., Denwood, M., Christiansen, L. E., Moller, C. H., Rasmussen, M., Cohen, A. S., Stegger, M., Fonager, J., Sieber, R., Ellegaard, K., Nielsen, C., Kirkeby, C. T.
10.1101/2022.01.06.22268841 — Posted: 2022-01-06
Updated projections for COVID-19 omicron wave in Florida
Hladish, T. J., Pillai, A. N., Longini, I. M.
10.1101/2022.01.06.22268849 — Posted: 2022-01-06 Discussion: Onsite
Evaluating Real-World COVID-19 Vaccine Effectiveness Using a Test-Negative Case-Control Design
Reynolds, M. W., Secora, A., Joules, A., Albert, L., Brinkley, E., Kwon, T., Mack, C. D., Toovey, S., Dreyer, N.
10.1101/2022.01.06.22268726 — Posted: 2022-01-06
Older Adults Mount Less Durable Humoral Responses to a Two-dose COVID-19 mRNA Vaccine Regimen, but Strong Initial Responses to a Third Dose
Mwimanzi, F. M., Lapointe, H. R., Cheung, P. K., Sang, Y., Yaseen, F., Umviligihozo, G., Kalikawe, R., Datwani, S., Omondi, F. H., Burns, L., Young, L., Leung, V., Ennis, S., Agafitei, O., Basra, S., Lim, L. Y., Ng, K., Pantophlet, R., Brumme, C. J., Montaner, J. S. G., DeMarco, M., Holmes, D. T., Simons, J., Niikura, M., Romney, M. G., Brumme, Z. L., Brockman, M. A.
10.1101/2022.01.06.22268745 — Posted: 2022-01-06
High Sensitivity and NPV for BinaxNOW Rapid Antigen Test in Children at a Mass Testing Site During Prevalent Delta Variant
Sun, K. J., Vaeth, M. J. E., Robinson, M. L., Elhabashy, M., Gupta, I., Purekal, S., Hammershaimb, E. A. D., Peralta, R., Mitchell, A., Foyez, M., Johnson, J. K., Ficke, J. R., Manabe, Y. C., Campbell, J. D., Callahan, C. W., Locke, C. F., Kantsiper, M., CONQUER COVID Consortium, , Siddiqui, Z. K.
10.1101/2022.01.05.22268788 — Posted: 2022-01-06
An integrated lab-on-a-chip device for RNA extraction, amplification and CRISPR-Cas12a-assisted detection for COVID-19 screening in resource-limited settings
Ngamsom, B., Iles, A., Kamita, M., Kimani, R., Rodriguez-Mateos, P., Mungai, M., Dyer, C. E., Walter, C., Gitaka, J., Pamme, N.
10.1101/2022.01.06.22268835 — Posted: 2022-01-06 Discussion: Offsite
The impact of vaccination on incidence and outcomes of SARS-CoV-2 infection in patients with kidney failure in Scotland
Bell, S., Campbell, J., Lambourg, E., Watters, C., O'Neill, M., Almond, A., Buck, K., Carr, E., Clark, L., Cousland, Z., Findlay, M., Joss, N., Metcalfe, W., Petrie, M., Spalding, E., Traynor, J., Sanu, V., Thomson, P., Methven, S., Mark, P.
10.1101/2022.01.05.22268785 — Posted: 2022-01-06
Diminished antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients
Al Jurdi, A., Benedetti Gassen, R., De Jesus Borges, T., Tadeval Lape, I., Morena, L., Efe, O., Solhjou, Z., El Fekih, R., Deban, C., Bohan, B., Pattanayak, V., Kotton, C., Azzi, J., Riella, L. V.
10.1101/2022.01.03.22268649 — Posted: 2022-01-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).